Preventing Central Catheter-Associated Bloodstream Infections

Sponsor
Abant Izzet Baysal University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04920877
Collaborator
(none)
100
1
6.9

Study Details

Study Description

Brief Summary

The research is an algorithm study focused on nursing care in order to prevent Central Catheter-Associated Bloodstream Infections in intensive care units. The algorithm prepared with infection control measures related to central catheter care will be applied with intensive care nurses and the effect of the algorithm on central catheter-related bloodstream infections will be examined. In practice, a 20-day preliminary assessment, a three-month intervention period, and a three-month post-intervention planning were made.

Condition or Disease Intervention/Treatment Phase
  • Other: Infection Prevention
N/A

Detailed Description

In the light of literature review and guidelines, intensive care nurses will care for central catheters through an algorithm created with infection control measures.

Nurse-focused algorithm content to prevent central catheter-related bloodstream infections Hand hygiene practice Use of personal protective equipment according to infection control measures Evaluation of the catheter insertion site in terms of redness, swelling, tenderness, discharge, bleeding Use of >0.5% chlorhexidine solution containing 70% alcohol for skin antisepsis at the catheter insertion site (if there is no chlorhexidine, povidone iodine + 70% alcohol solution is used) Changing the transparent, semi-permeable dressings every 5-7 days and gauze dressings every 48 hours for catheter dressing Catheter dressing with aseptic technique Use of sterile, preservative-free saline for flushing and locking in order to ensure the lumen of the catheter.

Aseptic conditions should be observed if the junction of the catheter and the infusion set (Hub) is to be touched.

Keeping the used triple taps closed Changing IV fluid sets and connection tools at appropriate times Daily assessment of CVC requirement The research will be carried out in the 1st, 2nd and 3rd Level Intensive Care Units of Bilecik Training and Research Hospital in Bilecik, Turkey. Infection rates will be compared in the study. In the study, the date of June 2021 will be taken as a preliminary assessment and training time for nurses. July-September 2021 will be the intervention period of the study, and October-December 2021 will be the post-intervention period.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Patients followed with a central catheter in the intensive care unitPatients followed with a central catheter in the intensive care unit
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
APPLICATION OF NURSE-FOCUSED ALGORITHM IN INTENSIVE CARE UNITS TO PREVENT CENTRAL CATHETER-RELATED BLOODSTREAM İNFECTİONS
Anticipated Study Start Date :
Jun 4, 2021
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Central catheter-related bloodstream infection rates in intensive care units

Other: Infection Prevention
Preventing central catheter-related bloodstream infections in intensive care units

Outcome Measures

Primary Outcome Measures

  1. Infection rate [Three months]

    Central catheter-related bloodstream infection rates in intensive care units

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • A central venous catheter was inserted in the intensive care unit or before the intensive care unit admission, and being followed up in the intensive care unit with a central venous catheter.
Exclusion Criteria:
  • Patients whose central venous catheter was terminated during intensive care follow-up.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Abant Izzet Baysal University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Aysun ACUN, Research Assistant, Gazi University
ClinicalTrials.gov Identifier:
NCT04920877
Other Study ID Numbers:
  • AIBU-SBF-AA-01
First Posted:
Jun 10, 2021
Last Update Posted:
Jun 10, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Aysun ACUN, Research Assistant, Gazi University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 10, 2021